Get started
Author

María Cecilia Foncuberta

Observed names: M Foncuberta, M. C Foncuberta, M. C. Foncuberta, M. Cecilia Foncuberta, M.C. Foncuberta, Maria C Foncuberta, Maria C. Foncuberta, Maria Cecilia FONCUBERTA, Maria Cecilia Foncuberta, María Foncuberta, María C Foncuberta
OpenAlex ID: A5079112414
Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma
2025 · Michael Wang, Michael Wang, et al. · Journal of Clinical Oncology · 67
Topical Transforming Growth Factor-β3 in the Prevention or Alleviation of Chemotherapy-Induced Oral Mucositis in Patients with Lymphomas or Solid Tumors
2001 · M. C. Foncuberta, P. J. Cagnoni, et al. · Journal of Immunotherapy · 52
Oxidative study of patients with total body irradiation: effects of amifostine treatment
2004 · G Facorro, M M Sarrasague, et al. · Bone Marrow Transplantation · 31
[Treatment of hematologic neoplasms during pregnancy].
2007 · Norma E Tartas, María C Foncuberta, et al. · PubMed · 5
Allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndrome: Experience of the Argentinean Group of Bone Marrow Transplantation (GATMO)
2015 · Ana L. Basquiera, María M. Rivas, et al. · Hematology · 3
PDF
Allogeneic hematopoietic stem cell transplantation in the elderly. Predicting the risk for non relapse mortality.
2015 · Mariano Berro, Ana L Basquiera, et al. · PubMed · 3
HCT.CI in Autologous Stem Cell Transplantation. Predicting Early and Late Transplant Related Mortality
2016 · Mariano Berro, Maria M Rivas, et al. · Blood · 2
Oral Mucosal Lymphomatoid Papulosis: a Case Report.
2024 · Andrea Karina GALLO, Luciana ROS, et al. · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · 1
Percentage of Infiltrating T Lymphocytes in Diffuse Large B-Cell Lymphoma Lymph Nodes Measured By Flow Cytometry Predicts Overall Survival and Provides Additional Prognostic Information When Combined with the R-IPI
2019 · Laura Korin, Maria Del Rosario Custidiano, et al. · Blood · 1
Autologous Stem Cell Transplantation (ASCT) with Benda-CV (Bendamustine, Cyclophosphamide, Etoposide) in Non-Hodgkin (non-HO) and Hodgkin (HL) Lymphoma Patients (pts)
2017 · Gregorio Jaimovich, Maria Belen Rosales Ostriz, et al. · Transplantation and Cellular Therapy · 1
Identification of Predictive Biomarkers Based on Cytokine Profiles for Molecular Relapse After Treatment-Free Remission in Chronic Myeloid Leukemia Patients
2026 · Bianca Vasconcelos Cordoba, Carolina Pavlovsky, et al. · Cells
PDF
[Innate immune memory - Trained immunity: Current concepts and clinical implications].
2026 · María Cecilia Foncuberta, Olivia Gelo, et al. · PubMed
Letermovir prophylaxis for cytomegalovirus infection in hematopoietic transplantation with post-transplant cyclophosphamide.
2025 · Olivia Gelo, Jorge Arbelbide, et al. · PubMed
[Normal and emergency hematopoiesis: current concepts and clinical implications].
2025 · Olivia Gelo, María Cecilia Foncuberta, et al. · PubMed
Decreased Incidence of CMV Infection with Letermovir Prophylaxis in Alternative Donor Allogeneic Hematopoietic-Cell Transplantation with Post-Transplant Cyclophosphamide, Real-Life Data from Argentina.
2024 · Olivia Gelo, Jorge Arbelbide, et al. · Transplantation and Cellular Therapy
High Doses of Chemotherapy and Autologous Hematopoietic STEM Cell Transplantation in Patients with Relapsed/Refractory Testicular GERM Cell Tumors. Multicenter Real-World Experience in Argentina.
2024 · Adriana Verónica Vitriu, Luis Eladio Ayala, et al. · Transplantation and Cellular Therapy
High doses of chemotherapy and autologous hematopoietic stem cell transplantation in patients with relapsed/refractory testicular germ cell tumors: Multicenter real-world experience in Argentina.
2024 · Federico Losco, Martin Angel, et al. · Journal of Clinical Oncology
PDF
High Progression Free Survival Rates in Patients with Multiply Relapsed/Refractory Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant after Checkpoint Inhibitors: Results from Grupo Argentino De Trasplante De Medula Osea y Terapia Celular (GATMO-TC)
2023 · Laura Korin, Martin Castro, et al. · Blood
PDF
Microenvironment Immune Cells in Bone Marrow and Lymph Node Measured By Flow Cytometry Have Prognostic Impact on Survival in Nodal Non-Hodgkin T-Cell Lymphoma
2022 · Laura Korin, Maria Lucia Fuente, et al. · Blood
241.6: Hematopoietic Cell Transplantation From Volunteer Unrelated Donor Between 2016 and 2021: A Collaborative Study GATMO-TC and INCUCAI
2022 · Ana Basquiera, Richard Malan, et al. · Transplantation
P1275: Percentage of Tumor Infiltrating T Lymphocytes Measured by Flow Cytometry at Diagnosis Predicts Survival After Salvage Chemotherapy in Relapsed/ Refractory Diffuse Large B Cell Lymphoma Patients.
2022 · L. Korin, M. Fuente, et al. · HemaSphere
Pb2265: Outcomes of Covid-19 Infection in Patients With B and Plasma Cell Malignancies During the Third Wave in Argentina: a Single Center Experience
2022 · O. Gelo, L. Korin, et al. · HemaSphere
Low Percentage of Microenvironment Immune Cells in Bone Marrow and Lymph Node Measured By Flow Cytometry Is Associated with Inferior Overall Survival in Diffuse Large B Cell Lymphoma
2021 · Laura Korin, Maria Lucia Fuente, et al. · Blood
Microenvironment Immune Cells in Bone Marrow and Lymph Node Measured by Flow Cytometry Can Predict Survival in Diffuse Large B Cell Lymphoma
2021 · L Korin, S Cranco, et al. · Hematological Oncology
PDF
In Pursuit of Surrogate Markers for Treatment-Free Remission in Patients with Chronic Myeloid Leukemia from Argentina Stop Trial
2020 · Maria Belen Sanchez, Beatriz Moiraghi, et al. · Blood
Works count: 40
Citation count: 165
H-index: 4
I10-index: 3
Year
Topic
Type